Home/Filings/4/0001209191-22-054725
4//SEC Filing

Gladstone Michael 4

Accession 0001209191-22-054725

CIK 0001923840other

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 4:49 PM ET

Size

5.9 KB

Accession

0001209191-22-054725

Insider Transaction Report

Form 4
Period: 2022-10-26
Gladstone Michael
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2022-10-26+13,66713,667 total
    Exercise: $17.83Exp: 2032-10-25Common Stock (13,667 underlying)
Footnotes (2)
  • [F1]The option vests over a 8-month period: 1/8th on October 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date.
  • [F2]The Reporting Person is a member of Atlas Venture Life Science Advisors, LLC ("Atlas") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Issuer

Third Harmonic Bio, Inc.

CIK 0001923840

Entity typeother

Related Parties

1
  • filerCIK 0001864256

Filing Metadata

Form type
4
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 4:49 PM ET
Size
5.9 KB